Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP601646.RA6Y1mLhh_O7_ExWVois_4LMEg-QbHeB5PaWddfn2Erd0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP601646.RA6Y1mLhh_O7_ExWVois_4LMEg-QbHeB5PaWddfn2Erd0130_assertion type Assertion NP601646.RA6Y1mLhh_O7_ExWVois_4LMEg-QbHeB5PaWddfn2Erd0130_head.
- NP601646.RA6Y1mLhh_O7_ExWVois_4LMEg-QbHeB5PaWddfn2Erd0130_assertion description "[CHRNA3 (rs1051730) genotyping can improve customized chemotherapy based on tumor assessment of ERCC1 mRNA in stage IV NSCLC with PS 0.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP601646.RA6Y1mLhh_O7_ExWVois_4LMEg-QbHeB5PaWddfn2Erd0130_provenance.
- NP601646.RA6Y1mLhh_O7_ExWVois_4LMEg-QbHeB5PaWddfn2Erd0130_assertion evidence source_evidence_literature NP601646.RA6Y1mLhh_O7_ExWVois_4LMEg-QbHeB5PaWddfn2Erd0130_provenance.
- NP601646.RA6Y1mLhh_O7_ExWVois_4LMEg-QbHeB5PaWddfn2Erd0130_assertion SIO_000772 19733931 NP601646.RA6Y1mLhh_O7_ExWVois_4LMEg-QbHeB5PaWddfn2Erd0130_provenance.
- NP601646.RA6Y1mLhh_O7_ExWVois_4LMEg-QbHeB5PaWddfn2Erd0130_assertion wasDerivedFrom befree-20140225 NP601646.RA6Y1mLhh_O7_ExWVois_4LMEg-QbHeB5PaWddfn2Erd0130_provenance.
- NP601646.RA6Y1mLhh_O7_ExWVois_4LMEg-QbHeB5PaWddfn2Erd0130_assertion wasGeneratedBy ECO_0000203 NP601646.RA6Y1mLhh_O7_ExWVois_4LMEg-QbHeB5PaWddfn2Erd0130_provenance.